NCT07185659

Brief Summary

"Patients were divided into two groups: the experimental group (E group) and the control group (C group). The E group received standard care, walking exercise, and elastic band exercise, and wore a smart bracelet to record walking steps and sleep for three months. During the first month, participants performed walking exercise for 100 minutes per week and used a red elastic band for resistance training. In the second month, walking exercise increased to 150 minutes per week with a green elastic band. In the third month, walking exercise increased to 150-300 minutes per week with a blue elastic band. The C group wore the smart bracelet to record walking steps and sleep for three months. Each group included 34 participants. The study was conducted from September 9, 2021, to December 31, 2025. Exclusion criteria included panic disorder, cognitive impairment, current cancer treatment, angina pectoris or myocardial infarction within the past 3 months, participation in high-intensity rehabilitation exercise, and walking dysfunction. Participants were required to follow the study protocol.

  • Assessments\*\*:
  • Anxiety and Depression\*\*:Measured using the Chinese version of the Hospital Anxiety and Depression Scale (HADS).
  • Dyspnea\*\*:Measured using the Modified Medical Research Council (mMRC) scale.
  • Life and Sleep quality\*\*:Measured using the COPD Assessment Test (CAT) and Chinese Version of the Pittsburgh Sleep Quality Index (CPSQI).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2023

Completed
2.6 years until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

4.3 years

First QC Date

February 19, 2023

Last Update Submit

September 18, 2025

Conditions

Keywords

Chronic obstructive pulmonary disease

Outcome Measures

Primary Outcomes (5)

  • Hospital Anxiety and Depression Scale (HADS)

    HADS was used to assess differences between groups and over time. The questionnaire consists of 14 items: 7 for anxiety and 7 for depression. Scores range from 0 to 21 for each subscale, with higher scores indicating greater levels of anxiety and depression.

    Patients were assessed before discharge as the baseline, and reassessed at 4, 8, and 12 weeks post-discharge.

  • modified Medical Research Council (mMRC)

    The mMRC scale was used to assess differences in dyspnea severity between groups over time. The mMRC is a five-point scale ranging from 0 (least severe) to 4 (most severe), with higher scores indicating greater dyspnea severity.

    Patients were assessed before discharge as the baseline, and reassessed at 4, 8, and 12 weeks post-discharge.

  • COPD Assessment Test (CAT)

    The COPD Assessment Test (CAT) was used to assess differences between groups over time. The CAT consists of 8 items scored from 0 to 5, yielding a total score of 0 to 40, with higher scores indicating a greater impact of COPD on quality of life.

    Patients were assessed before discharge as the baseline, and reassessed at 4, 8, and 12 weeks post-discharge.

  • Chinese Version of the Pittsburgh Sleep Quality Index (CPSQI)

    CPSQI was used to assess differences between groups over time. Scores range from 0 to 21, with higher scores indicating poorer sleep quality. A score greater than 5 denotes poor sleep quality.

    Patients were assessed before discharge as the baseline, and reassessed at 4, 8, and 12 weeks post-discharge.

  • Six-Minute Walk Test ( 6MWT )

    The six-minute walk test (6MWT) was used to assess differences between groups and over time. It is an important measure of patients' functional exercise capacity.

    Patients were assessed before discharge as the baseline, and reassessed at 4, 8, and 12 weeks post-discharge.

Secondary Outcomes (7)

  • Daily walking activity:(1)total steps

    Patients were monitored over a 12-week period, with formal assessments conducted at 4, 8, and 12 weeks post-discharge.

  • Daily walking activity:(2)total walking distance

    Patients were monitored over a 12-week period, with formal assessments conducted at 4, 8, and 12 weeks post-discharge.

  • Sleep status : (1)daily total sleep duration

    Patients were monitored over a 12-week period, with formal assessments conducted at 4, 8, and 12 weeks post-discharge.

  • Sleep status : (2)daily light sleep duration

    Patients were monitored over a 12-week period, with formal assessments conducted at 4, 8, and 12 weeks post-discharge.

  • Sleep status : (3) Daily deep sleep duration

    Patients were monitored over a 12-week period, with formal assessments conducted at 4, 8, and 12 weeks post-discharge.

  • +2 more secondary outcomes

Study Arms (2)

walking exercise and resistance exercise with elastic band

EXPERIMENTAL

From weeks 1 to 12, participants' daily walking steps were monitored using a wearable device (smart bracelet). Participants performed walking exercises 5 days per week, twice daily (morning and evening sessions). In weeks 1-4, the prescribed dose was 100 minutes per week (10 minutes per session); in weeks 5-8, 150 minutes per week (15 minutes per session); and in weeks 9-12, 150 to 300 minutes per week (20 to 30 minutes per session). Leg resistance extension exercises were also performed with progressively stronger elastic bands: red (weeks 1-4), green (weeks 5-8), and blue (weeks 9-12). During weeks 1-2 and 5-6, exercises were performed 3 times per week with 2 sets per session, which increased to 3 sets per session during weeks 3-4, 7-8, and 11-12.

Device: Elastic bandDevice: Xiaomi Mi Band 4 wearable deviceBehavioral: Walking

routine nursing care and health education

PLACEBO COMPARATOR

Participants received routine nursing care and health education. From weeks 1 to 12, their daily walking steps were monitored using a wearable device (smart bracelet)

Device: Xiaomi Mi Band 4 wearable device

Interventions

Thera-Band® elastic band exercise protocol: First stage (weeks 1-4): Participants performed leg resistance stretching exercises with a red elastic band. In weeks 1-2, exercises were performed 3 times per week, with 2 sets per session; in weeks 3-4, 3 times per week, with 3 sets per session. Second stage (weeks 5-8): Participants performed leg resistance stretching exercises with a green elastic band. In weeks 5-6, exercises were performed 3 times per week, with 2 sets per session; in weeks 7-8, 3 times per week, with 3 sets per session. Third stage (weeks 9-12): Participants performed leg resistance stretching exercises with a blue elastic band. In weeks 9-10, exercises were performed 3 times per week, with 2 sets per session; in weeks 11-12, 3 times per week, with 3 sets per session.

walking exercise and resistance exercise with elastic band

The Xiaomi Mi Band 4 wearable device has been certified by the National Communications Commission (Certification No. CCAG19LP0080T6). From weeks 1 to 12, participants' daily walking steps were monitored using the Xiaomi Mi Band 4 wearable device.

routine nursing care and health educationwalking exercise and resistance exercise with elastic band
WalkingBEHAVIORAL

Walking exercise plan

walking exercise and resistance exercise with elastic band

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients diagnosed with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.
  • Age ≥ 40 years.
  • Post-bronchodilator FEV₁/FVC ratio \< 70%.
  • History of smoking.
  • Ability to perform walking exercises.
  • Willingness of the patient or a family member to provide written informed consent.

You may not qualify if:

  • Panic disorder.
  • Presence of delirium with inability to cooperate.
  • Currently receiving cancer treatment.
  • Angina pectoris or myocardial infarction within the past 3 months.
  • Currently undergoing high-intensity rehabilitation exercises.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Tzu Chi Hospital

New Taipei City, Xindian Dist., 23142, Taiwan

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Walking

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Pei-Ching Hung, Hand nurse

    Taipei Tzuchi hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pei-Ching Hung, Head nurse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients were randomly assigned to either the experimental group (E group) or the control group (C group). The experimental group received standard care, walking exercise, and elastic band exercise, and wore a smart bracelet to record walking steps and sleep for three months. During the first month, participants performed walking exercise for 100 minutes per week and used a red elastic band for resistance training. In the second month, walking exercise increased to 150 minutes per week with a green elastic band. In the third month, walking exercise increased to 150-300 minutes per week with a blue elastic band. The control group wore a smart bracelet to record walking steps and sleep for three months but did not participate in the structured exercise program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
HEAD NURSE

Study Record Dates

First Submitted

February 19, 2023

First Posted

September 22, 2025

Study Start

September 9, 2021

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Protecting participant privacy is the primary consideration, as sharing individual participant data (IPD) could expose sensitive information and create risks of re-identification, even after de-identification. Moreover, participants did not provide consent for data sharing, and obtaining re-consent would be difficult. Ensuring data security also requires substantial resources and technical safeguards that exceed our current infrastructure. In addition, compliance with complex legal and ethical regulations governing data sharing further complicates implementation. Finally, maintaining the quality and integrity of IPD prior to sharing demands additional effort and resources. Collectively, these factors inform our decision to prioritize participant protection and data security.

Locations